Search Results - "psoriasis"

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study by Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini, Salvatore Corrao, Annamaria Offidani, Luca Stingeni, Antonio Costanzo, Giovanni Pellacani, Ketty Peris, Federico Bardazzi, Giuseppe Argenziano, Silvana Ruffolo, Paolo Dapavo, Carlo Carrera, Maria Concetta Fargnoli, Aurora Parodi, Marco Romanelli, Piergiorgio Malagoli, Marina Talamonti, Matteo Megna, Massimo Raspanti, Matteo Paolinelli, Katharina Hansel, Alessandra Narcisi, Andrea Conti, Clara De Simone, Marco Adriano Chessa, Alina De Rosa, Eugenio Provenzano, Michela Ortoncelli, Chiara Moltrasio, Rosaria Fidanza, Martina Burlando, Annalisa Tonini, Francesca Maria Gaiani, Lucia Simoni, Alessandro Zullo, Martina Fiocchi, Delia Colombo

Connect to this object online.

Psoriasis en tratamiento biológico durante la pandemia COVID-19: serie de pacientes del Hospital Universitario Son Espases by I. Gracia-Darder, J. Garcías-Ladaria, D. Ramos Rodríguez, J. Escalas Taberner

Connect to this object online.

Salidroside inhibits MAPK, NF-κB, and STAT3 pathways in psoriasis-associated oxidative stress via SIRT1 activation by Fengli Xu, Jixiang Xu, Xia Xiong, Yongqiong Deng

Connect to this object online.

Izokibep: Preclinical development and first-in-human study of a novel IL-17A neutralizing Affibody molecule in patients with plaque psoriasis by Susanne Klint, Joachim Feldwisch, Lindvi Gudmundsdotter, Karin Dillner Bergstedt, Elin Gunneriusson, Ingmarie Höidén Guthenberg, Anders Wennborg, Andrew C. Nyborg, Amol P. Kamboj, Paul M. Peloso, David Bejker, Fredrik Y. Frejd

Connect to this object online.

Correction: Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic by Ashis K. Das, Eunice Chang, Caleb Paydar, Michael S. Broder, Kate K. Orroth, Myriam Cordey

Connect to this object online.

Rapid Response of Biologic Treatments of Moderate-to-Severe Plaque Psoriasis: A Comprehensive Investigation Using Bayesian and Frequentist Network Meta-analyses by Richard B. Warren, Kyoungah See, Russel Burge, Ying Zhang, Alan Brnabic, Gaia Gallo, Alyssa Garrelts, Alexander Egeberg

Connect to this object online.

Common contact allergens in patients with palmoplantar and scalp psoriasis and impact of their avoidance on dermatology life quality index: A hospital-based study by Farhan Rasool, Saniya Akhtar, Iffat Hassan, Sumaya Zeerak, Syed Mubashir, Gousia Sheikh

Connect to this object online.

Nail Psoriasis in a Child Observed Under Ultraviolet Dermoscopy Treated by a Topical Biological Agent Cream: A Case Report by Run-Yan Gao, Sushmita Pradhan, Yu-Ping Ran

Connect to this object online.

Exploring the Correlation between the PASI and DLQI Scores in Psoriasis Treatment with Topical Ointments Containing <i>Rosa × damascena</i> Mill. Extract by Diana Ioana Gavra, Dóra Kósa, Ágota Pető, Liza Józsa, Zoltán Ujhelyi, Pálma Fehér, Annamária Pallag, Timea Claudia Ghitea, Simona Frățilă, Tünde Jurca, Ildikó Bácskay

Connect to this object online.

Bimekizumab as treatment for moderate to severe chronic plaque psoriasis: Real world clinical experience from a district general hospital setting by Omowunmi Ashaolu, Tracy Smith, Amie Askins, Suchitra Rajan, Vincent Li, Sandeep Kamath, Jenny Hughes, Geraldine Haebich

Connect to this object online.

Efficacy and safety of risankizumab for moderate-to-severe plaque psoriasis in clinical practice: A 16-week Canadian retrospective multicenter cohort study by Yuliya Lytvyn, PhD, Asfandyar Mufti, MD, Hiba Zaaroura, MD, Muskaan Sachdeva, BHSc, Justin D. Lu, MSc, Brian D. Rankin, PhD, Vimal H. Prajapati, MD, Ronald Vender, MD, Jensen Yeung, MD, FRCPC

Connect to this object online.

Musculoskeletal Pain in Patients with Psoriasis and its Influence on Health-related Quality of Life: Results from a Danish Population-based Survey by Sara Kamp Felbo, Lene Terslev, Inge Juul Sørensen, Lone Skov, Claus Zachariae, Mikkel Østergaard

Connect to this object online.

Clinic-based group multi-professional education causes significant decline in psoriasis severity: A randomized open label pilot study by Shubh Mohan Singh, Tarun Narang, Keshavamurthy Vinay, Aditi Sharma, Ashirbad Satapathy, Sanjeev Handa, Sunil Dogra

Connect to this object online.

Impact of Adverse Events Associated With Acitretin Treatment of Moderate-to-Severe Plaque Psoriasis: Based on an Observational, Single-Center Study in Shanghai, China by Xiao-Yuan Zhong, Ying Li, Rui Ma, Xin Wang, Ying-Yuan Yu, Ning Yu, Yang-Feng Ding, Jia-Jing Lu, Yu-Ling Shi

Connect to this object online.

Google Search Trends About Systemic Psoriasis Treatment: What Do People Want to Know About Biologics and Janus Kinase Inhibitors? by Subin Lim, Sarah Kooper-Johnson, Courtney A Chau, Claire Chen, Fei-Shiuann Clarissa Yang, Gabriela Cobos

Connect to this object online.

Factors Affecting Treatment Persistence in Japanese Patients with Psoriasis Prescribed Biologics: A Real-World Study Using an Insurance Claim Database by Celine Miyazaki, Junya Masuda, Phiona I-Ching Tsai, Hidehisa Saeki

Connect to this object online.

Prevalence and Impact of Unacceptable Symptom State among Patients with Psoriatic Arthritis: Results from the National Psoriasis Foundation's 2019 Annual Survey by Melissa P. Zundell, Alexis R. Ogdie-Beatty, Lourdes Perez-Chada, Hassan Hamade, George C. Gondo, Ali T. Khan, Stacie J. Bell, Zachary Levy, Joseph F. Merola, Alice B. Gottlieb

Connect to this object online.

OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting by Sarah Alulis, Nicoletta Bernardini, Martina Burlando, Antonio Costanzo, Pier Cesare Francesa Morel, Paolo Gisondi, Francesco Loconsole, Matteo Megna, Giovanni Pellacani, Stefano Piaserico, Francesca Prignano, Ottavio Secchi, Nevena Skroza, Fareen Hassan

Connect to this object online.

Antiproliferative and Anti-Inflammatory Activities of Deprungsith Formulation and Its Bioactive Compounds Against Mild Psoriasis and Potential of Metabolic Herb-Drug Interactions by Kesara Na-Bangchang PhD, Monthaka Teerachaisakul PhD, Phunuch Muhamad PhD, Yositha Kasemnitichok BSc, Nattida Sangnarong BSc, Kanyarat Boonprasert PhD, Mayuri Tarasuk PhD, Tullayakorn Plengsuriyakarn PhD

Connect to this object online.

Dimethyl Fumarate Targets MSK1, RSK1, 2 and IKK&alpha;/&beta; Kinases and Regulates NF-&kappa;B /p65 Activation in Psoriasis: A Demonstration of the Effect on Peripheral Blood Mononuclear Cells, Drawn from Two Patients with Severe Psoriasis Before and After Treatment with Dimethyl Fumarate by Gesser B, Rasmussen MK, Iversen L

Connect to this object online.